NCT02741518View on ClinicalTrials.gov

Fecal Microbiota Transplantation for the Treatment of Obesity

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

October 18, 2018

Study Completion Date

July 24, 2019

Conditions
Obesity
Interventions
BIOLOGICAL

Fecal Microbiota Transplantation

This is pre-screened fecal material that has been encapsulated

OTHER

Placebo

These are capsules that have no fecal material in them.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT02741518 - Fecal Microbiota Transplantation for the Treatment of Obesity | Biotech Hunter | Biotech Hunter